U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
The U.S. Army's missile stockpile is dwindling and could take years to replenish. And, the Food and Drug Administration is deciding whether to approve a flu vaccine with mRNA technology.
Brief by WorldPing · Original reporting by NPR
WorldPing